Period Ending | Dec 30, 2011 | Sep 29, 2011 |
---|
Total Revenue
|
19,420,000
|
20,616,000
| Cost of Revenue | 17,711,000 | 16,976,000 | |
Gross Profit
|
1,709,000
|
3,640,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
|
Selling General and Administrative | 1,658,000 | 1,691,000 |
|
Non Recurring |
-
|
-
|
|
Others | 230,000 | 227,000 |
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
(179,000)
|
1,722,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 12,000 | 22,000 |
|
Earnings Before Interest And Taxes | (180,000) | 1,744,000 |
|
Interest Expense |
-
|
-
|
|
Income Before Tax | (180,000) | 1,744,000 |
|
Income Tax Expense | (105,000) | 611,000 |
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | (66,000) | 1,148,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
(75,000)
|
1,133,000
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
(75,000)
|
1,133,000
|
|